KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Income towards Parent Company (2017 - 2025)

Elanco Animal Health's Income towards Parent Company history spans 9 years, with the latest figure at -$276.0 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company fell 3350.0% year-over-year to -$276.0 million; the TTM value through Dec 2025 reached -$232.0 million, down 168.64%, while the annual FY2025 figure was -$232.0 million, 168.64% down from the prior year.
  • Income towards Parent Company for Q4 2025 was -$276.0 million at Elanco Animal Health, down from -$34.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $364.0 million in Q3 2024 and bottomed at -$1.1 billion in Q3 2023.
  • The 5-year median for Income towards Parent Company is -$48.0 million (2022), against an average of -$84.6 million.
  • The largest annual shift saw Income towards Parent Company soared 179.69% in 2022 before it tumbled 3350.0% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$103.0 million in 2021, then surged by 55.34% to -$46.0 million in 2022, then tumbled by 206.52% to -$141.0 million in 2023, then surged by 94.33% to -$8.0 million in 2024, then crashed by 3350.0% to -$276.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Income towards Parent Company are -$276.0 million (Q4 2025), -$34.0 million (Q3 2025), and $11.0 million (Q2 2025).